Enclomiphene is a selective estrogen receptor modulator (SERM) studied in men with secondary or functional hypogonadism. It can raise testosterone while stimulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH).1 No enclomiphene product is approved by the U.S. Food and Drug Administration (FDA).2 Any enclomiphene dose requires a prescriber to interpret your labs, symptoms, fertility goals, and response over time.
How Enclomiphene Changes Hormone Signaling
Enclomiphene is the trans-isomer of clomiphene citrate. It belongs to the SERM drug class.
A published review found that enclomiphene increased testosterone while stimulating LH and FSH production.1 These hormone changes distinguish the treatment from testosterone replacement therapy (TRT), which supplies testosterone from outside the body.
Total testosterone alone does not describe the full response. Your physician also needs to see what happens to LH, FSH, and your symptoms after treatment begins. For a detailed isomer comparison, read enclomiphene vs Clomid.
FDA Status and the 503A Decision
There is no FDA-approved enclomiphene product.
Enclomiphene citrate was nominated for the 503A Bulks List for compounding. The nominated use was to increase testosterone, LH, and FSH to normal levels in secondary hypogonadism. The FDA proposed that enclomiphene citrate should not be included on the list.2
The Pharmacy Compounding Advisory Committee considered the nomination in June 2022. Eight members voted against adding enclomiphene citrate, while four voted in favor. No members abstained.2
Several members who voted against inclusion cited a lack of clinical efficacy evidence. One committee member stated that more studies needed to be conducted.2 The vote did not create an FDA-approved enclomiphene product.
Clomiphene citrate has a different regulatory record. It is FDA-approved for ovarian dysfunction, while its use for male hypogonadism is off-label.1 The clinical use of clomiphene in men is covered separately.
A search for where to buy enclomiphene therefore leads to the compounding route. It does not lead to an FDA-approved enclomiphene medication. Before accepting a prescription, you need a physician to explain the regulatory status, the treatment rationale, and how your response will be measured.
Enclomiphene Dose Selection Under Physician Care
An enclomiphene dose is a prescribing decision because the available sources do not establish one dose, strength, schedule, or treatment duration for every man. A specific capsule strength circulating online does not become a personal recommendation.
Your prescriber has to connect the dose decision to your diagnosis, baseline testosterone, LH, FSH, symptoms, and fertility plans. Follow-up values then show how your hormone signaling responded. A single testosterone result cannot provide that pattern.
The same rule applies to duration. The available evidence does not establish a universal treatment calendar. Your physician needs repeat labs and a symptom review before deciding whether the prescription should continue or change.
A testosterone blood test supplies part of the baseline. The treatment decision depends on related hormones and your clinical history as well.
Fertility in SERM Therapy and TRT
Fertility is the main clinical distinction between SERM therapy and TRT. Exogenous testosterone can suppress fertility, which has led to the use of SERMs that aim to correct hypogonadism without reducing fertility.1
A 2025 systematic review and meta-analysis found no statistically significant difference in total testosterone between SERM therapy and testosterone gel. However, LH and FSH were higher with SERM therapy.3 Those are class-level findings that combine clomiphene and enclomiphene trials. They cannot be assigned to enclomiphene alone.
If you want children, discuss fertility before starting either treatment. Your physician can then interpret your hormone pattern and explain whether preserving internal testosterone signaling belongs in the treatment plan. The broader clinical use of testosterone replacement therapy is covered separately.
Evidence for Hormone Changes
The strongest evidence in the available sources concerns SERM therapy as a class. The 2025 meta-analysis pooled randomized controlled trials involving clomiphene or enclomiphene in men with functional hypogonadism.3
Compared with placebo, SERM therapy increased total testosterone by a mean difference of 273.76 ng/dL. The reported 95% confidence interval was 191.87 to 355.66 ng/dL. SERM therapy also increased LH by 4.66 IU/L and FSH by 4.59 IU/L compared with placebo.3
The same analysis found no statistically significant difference in total testosterone between SERM therapy and testosterone gel. LH and FSH were higher in the SERM groups.3
These results concern hormone measurements. They do not establish improvements in muscle mass, strength, body composition, or physique. Your physician still needs to connect repeat hormone results with your symptoms and treatment goals.
hCG Comparisons Under Available Evidence
Human chorionic gonadotropin (hCG) and enclomiphene cannot be ranked from the available evidence because no cited source reports a head-to-head comparison.
A physician can instead assess your diagnosis, fertility goal, and lab pattern. That clinical review provides a sounder basis for choosing between treatments than an unsupported online ranking.
Treatment Fit Under Physician Review
Enclomiphene may enter the discussion when your labs and symptoms support secondary or functional hypogonadism, especially when fertility remains part of your plan. The evidence supports a physician considering hormone signaling and reproductive goals together.1,3
Enclomiphene does not suit anyone seeking an FDA-approved enclomiphene product, since no such product exists.2 It also does not support self-directed dosing or claims about physique outcomes that the cited studies did not measure.
Low testosterone can have different clinical causes. The hypogonadism guide covers those causes and how a physician evaluates them. Your next step is a complete lab assessment interpreted alongside your symptoms and fertility plans.
Enclomiphene is prescribed remotely under the same federal rules as testosterone. The prescribing rules for online TRT sets out what those are. Estradiol is one of the measures the enclomiphene trials tracked. the male estradiol reference interval explains the male reference interval it is read against.
The Opt Take on Enclomiphene
A physician should interpret your hormone results against your symptoms and goals, build the treatment plan, and adjust it after follow-up. Testing alone leaves the clinical decision unfinished.
At Opt Health, care begins with more than 55 biomarkers and a one-on-one physician review. Labs and physician consultations repeat every three to four months. Your plan changes according to what your numbers and symptoms show over time.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Enclomiphene is a SERM that increases testosterone while stimulating LH and FSH production.1 Those changes reflect continued internal hormone signaling. Your physician can measure testosterone, LH, and FSH before treatment and again during follow-up.
No enclomiphene product is FDA-approved. The FDA proposed excluding enclomiphene citrate from the 503A Bulks List, and an advisory committee voted eight to four against its inclusion.2 Several members cited insufficient clinical efficacy evidence.
The available sources do not report a defined time to effect for enclomiphene. Response should be judged through repeat labs and symptoms. Your prescriber sets the follow-up plan and decides whether the measured response supports continuing or changing treatment.
The available class-level evidence found no statistically significant difference in total testosterone between SERM therapy and testosterone gel. LH and FSH were higher with SERM therapy.3 The analysis included both clomiphene and enclomiphene trials, so it does not establish equivalence between enclomiphene and TRT.
Fertility changes the decision. Testosterone can suppress fertility, while SERMs aim to raise testosterone without reducing fertility.1
Your enclomiphene dose must be set by a prescriber. The cited evidence does not establish a universal dose, capsule strength, schedule, or treatment duration.
A specific capsule strength circulating online does not account for your baseline testosterone, LH, FSH, symptoms, or fertility plans. Your physician should set the prescription and reassess it with repeat labs.
A retrospective, single-center study followed 66 patients who received clomiphene and later enclomiphene. Enclomiphene was associated with lower odds of adverse events, with an odds ratio of 0.18 and a 95% confidence interval of 0.07 to 0.44.4
Decreased libido, reduced energy, and mood changes were less frequent with enclomiphene in that study.4 The study was not a long-term safety trial, and its authors called for larger studies. Your physician should review symptoms and repeat labs throughout treatment.
References
- Earl JA, Kim ED. Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism. Expert Rev Endocrinol Metab. 2019;14(3):157-165. https://pubmed.ncbi.nlm.nih.gov/31063005/
- U.S. Food and Drug Administration. Final Summary Minutes of the Pharmacy Compounding Advisory Committee Meeting, June 8, 2022. FDA Center for Drug Evaluation and Research. https://www.fda.gov/media/161293/download
- Hohl A, Chavez MP, Pasqualotto E, Ferreira ROM, et al. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Arch Endocrinol Metab. 2025;69(5):e250093. https://pubmed.ncbi.nlm.nih.gov/41066380/
- Saffati G, Kassab J, Orozco Rendon D, Hinojosa-Gonzalez DE, et al. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024;13(9):1984-1990. https://pubmed.ncbi.nlm.nih.gov/39434750/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.